Cellectis (CLLS) Cash & Current Investments: 2014-2023
Historic Cash & Current Investments for Cellectis (CLLS) over the last 9 years, with Sep 2023 value amounting to $67.4 million.
- Cellectis' Cash & Current Investments fell 43.40% to $67.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $347.5 million, marking a year-over-year decrease of 43.43%. This contributed to the annual value of $3.5 million for FY2022, which is 75.38% down from last year.
- Per Cellectis' latest filing, its Cash & Current Investments stood at $67.4 million for Q3 2023, which was down 21.21% from $85.5 million recorded in Q2 2023.
- Cellectis' Cash & Current Investments' 5-year high stood at $421.8 million during Q1 2019, with a 5-year trough of $67.4 million in Q3 2023.
- Moreover, its 3-year median value for Cash & Current Investments was $153.6 million (2022), whereas its average is $150.0 million.
- In the last 5 years, Cellectis' Cash & Current Investments skyrocketed by 49.55% in 2019 and then crashed by 44.35% in 2023.
- Quarterly analysis of 5 years shows Cellectis' Cash & Current Investments stood at $360.9 million in 2019, then fell by 25.68% to $268.2 million in 2020, then slumped by 30.61% to $186.1 million in 2021, then plummeted by 43.90% to $104.4 million in 2022, then plummeted by 43.40% to $67.4 million in 2023.
- Its Cash & Current Investments was $67.4 million in Q3 2023, compared to $85.5 million in Q2 2023 and $90.2 million in Q1 2023.